Clinical Trials Sponsored by Halcygen Pharmaceuticals Limited

Total 585 results

Hanmi Pharmaceutical Company Limited

Completed

PK and Safety Study of HCP1102, HGP0813 and HGP1408

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470

Diabetes Mellitus

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers

Pulmonary Arterial Hypertension

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male Volunteers

Healthy
Hanmi Pharmaceutical Company Limited

Completed

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules

Benign Prostatic Hyperplasia
Hanmi Pharmaceutical Company Limited

Completed

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH

Benign Prostate Hyperplasia

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Evaluating the Bioequivalence of HIP1302, HGP1406

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Efficacy and Safety of Morning Versus Evening Intake of Simvast Controlled Release (CR) Tablet in Patients With Hyperlipidemia

Hyperlipidemia

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients

Coronary Artery Disease (CAD)
Hanmi Pharmaceutical Company Limited

Completed

Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension

Hypertension

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Unknown

Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude

Chronic Hepatitis B

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies

Solid Tumor | Advanced Cancer

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mg

Diabetes Mellitus

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Study of HM10760A (Long-acting Erythropoietin) in Healthy Adult Caucasian and Japanese Subjects (EPO)

Healthy

United States
Hanmi Pharmaceutical Company Limited

Completed

Assess the Safety, Tolerability, and Pharmacokinetic (PK) Characteristics of HM10460A (HNK460) in Healthy Adult Korean Subjects

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients

Asthma

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose Combination

Rhinitis

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 Capsule

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Clinical Trial to Determine the MTD of HM781-36B in Patients With Advanced Solid Tumors

Advanced Solid Malignancies

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.

Hypertension
Hanmi Pharmaceutical Company Limited

Completed

Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of HIP0901 Capsule

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102)

Advanced Solid Malignancies

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Unknown

Efficacy and Safety of Simvast Controlled Release (CR) and Zocor in Chronic Kidney Disease(CKD) Stage 3, 4 and 5 Patients With Hyperlipidemia (HM-SIM4)

Chronic Kidney Disease | Hyperlipidemia

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Bioequivalence Study Comparing Clopidogrel/Aspirin Combination Tablet With Coadministration of Clopidogrel and Aspirin

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan

Healthy

Czech Republic
Hanmi Pharmaceutical Company Limited

Completed

Duration of P-glycoprotein Inhibition After Oral Administration of HM30181AK Tablet (PGP inhibitor)

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension

Hypertension

Korea, Republic of
Sun Pharmaceutical Industries Limited

Completed

Letrozole vs. Clomiphene Citrate in Patients With Anovulatory Infertility

Infertility

India
Lee's Pharmaceutical Limited
China Oncology Focus Limited

Withdrawn

Study of TG02 Citrate in Patients With Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma
Hanmi Pharmaceutical Company Limited

Not yet recruiting

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Recruiting

Dose Escalation and Expansion Study of BH3120 in Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors

Korea, Republic of, United States
Hanmi Pharmaceutical Company Limited

Recruiting

Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors

Korea, Republic of, Australia
Emzor Pharmaceutical Industries Limited

Not yet recruiting

Bioequivalence Study of Sulfadoxine/ Pyrimethamine Dispersible Tablets in Healthy Subjects Under Fasting Conditions

Bioequivalence
Hanmi Pharmaceutical Company Limited

Recruiting

Phase 2 Study to Assess the Safety, PK, and PD in SBS-IF Subjects

Short Bowel Syndrome

Belgium, Korea, Republic of, United States, Germany, Denmark, France, Poland
Sun Pharmaceutical Industries Limited

Recruiting

To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis (SOLARES-AD-1)

Dermatitis, Atopic

United States, El Salvador
Sun Pharmaceutical Industries Limited

Recruiting

To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis (SOLARES-PsO-1)

Moderate to Severe Plaque Psoriasis

United States, El Salvador
Sun Pharmaceutical Industries Limited

Recruiting

A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis

Moderate-to-severe Chronic Plaque Psoriasis

United States, Hungary, India, Poland, Slovakia, Spain
Sun Pharmaceutical Industries Limited

Active, not recruiting

A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne

Acne Vulgaris

United States
Sun Pharmaceutical Industries Limited

Active, not recruiting

A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne

Acne Vulgaris

United States
Sun Pharmaceutical Industries Limited

Completed

Effect of Cequa™ in Subjects With Dry Eye Disease

Dry Eye Disease

United States
Sun Pharmaceutical Industries Limited

Completed

A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Primary Open Angle Glaucoma | Ocular Hypertension

India, Russian Federation
Hanmi Pharmaceutical Company Limited

Completed

Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP1802 to HGP1705 in Healthy Volunteers

Healthy Volunteer

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers

Healthy Volunteer

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential Hypertension (HM_APOLLO)

Hypertension

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate the Drug-drug Interaction and Safety of RLD2301 and RLD2007 in Healthy Volunteers

Healthy Volunteers

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate the PK, Safety and Tolerability of HCP1803.

Healthy

Korea, Republic of
Sun Pharmaceutical Industries Limited

Completed

Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis

Scalp Psoriasis

United States, Australia
Hanmi Pharmaceutical Company Limited

Completed

Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux Disease

Non-erosive Gastroesphageal Reflux Disease

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet

Hypertension,Essential

Korea, Republic of

3

Subscribe